Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - ALSERES PHARMACEUTICALS INC /DE | b86113e10vq.htm |
| EX-31.2 - EX-31.2 - ALSERES PHARMACEUTICALS INC /DE | b86113exv31w2.htm |
| EX-31.1 - EX-31.1 - ALSERES PHARMACEUTICALS INC /DE | b86113exv31w1.htm |
| EX-32.2 - EX-32.2 - ALSERES PHARMACEUTICALS INC /DE | b86113exv32w2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Alseres Pharmaceuticals, Inc. (the “Company”) on Form
10-Q for the quarter ended March 31, 2011 as filed with the Securities and Exchange Commission (the
“Report”), I, Peter G. Savas, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
| /s/ Peter G. Savas | ||||
| Peter G. Savas | ||||
| Chief Executive Officer | ||||
Date: May 13, 2011